$46.98+0.01 (+0.02%)
Omega Healthcare Investors, Inc.
Omega Healthcare Investors, Inc. in the Real Estate sector is trading at $46.98. The stock is currently near its 52-week high of $49.14, remaining 9.5% above its 200-day moving average. Technical signals show neutral RSI of 62 and bullish MACD crossover, explaining why OHI maintains its current momentum and trend strength. The Whystock Score of 75/100 reflects a high-conviction bullish alignment.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Omega Healthcare Investors, Inc. is a Real Estate Investment Trust (REIT) providing financing and capital to the long-term healthcare industry in the United States and the United Kingdom with a focus on skilled nursing and assisted living facilitie...
Over the last 7 days, the United States market has remained flat, yet it is up 29% over the past year with earnings forecast to grow by 16% annually. In this environment, dividend stocks that offer consistent payouts and potential for growth can be appealing options for investors seeking stability and income.
First quarter adjusted funds from operations, AFFO, of $0.82 per share and FAD, funds available for distribution, of $0.78 per share reflect strong revenue and EBITDA growth principally fueled by acquisitions and active portfolio management. This along with a robust pipeline of investment opportunities gave us comfort to be able to increase the low end of our AFFO guidance, moving the midpoint up by $0.02 to $3.22.
Moby summary of Omega Healthcare Investors, Inc.'s Q1 2026 earnings call
In the last week, the United States market has stayed flat but is up 29% over the past year, with earnings forecast to grow by 16% annually. In such a dynamic environment, identifying dividend stocks that offer consistent returns can be a prudent strategy for building a resilient portfolio.
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of +2.50% and +2.20%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?